2005

Dec 27, 2005
Guidant Announces FDA Warning Letter Related to Prior FDA Inspection of St. Paul Facility

Company Will Promptly and Fully Respond to FDA Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today that it has received a warning letter from the U.S. Food and Drug Administration...

Dec 13, 2005
Guidant Enrolls First Patient in Japan Arm of Drug Eluting Stent Trial

SPIRIT III U.S. Randomized Enrollment Passes Halfway Mark Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has begun enrollment in the Japan arm of its SPIRIT...

Dec 12, 2005
Guidant Announces European Approval of Innovative Heart Failure Lead

Advanced Lead is Designed to Enable Physicians to Overcome Challenging Left Ventricular Anatomy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced Conformité...

Dec 7, 2005
Guidant Prepared to Enter into Discussions with Boston Scientific

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that its Board of Directors has made the requisite determination under Guidant's merger agreement with Johnson & Johnson to...

Dec 5, 2005
Guidant Acknowledges Receipt of Boston Scientific Proposal

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) acknowledges receipt of a letter dated today, , outlining a proposed transaction with Boston Scientific. Guidant's Board of Directors will...

Show 5102550100 per page
Top